DAVID LARNED: Open Payments
NPI 1487712212 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 36 payments from 9 companies in 2025. Trend: 2023 $1,392 · 2024 $781 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $205 |
| Neurocrine BioSciences, Inc. | 5 | $185 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| Teva Pharmaceuticals USA, Inc. | 5 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Lundbeck LLC | 3 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, COBENFY, UZEDY, ABILIFY ASIMTUFII, CAPLYTA, FANAPT, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
